3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Central Nervous System Neoplasms
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
pembrolizumab
2
cabozantinib
2
sodium thiosulfate
1
relacorilant
1
fludarabine phosphate
1
cemiplimab
1
Nivolumab
1
Ipilimumab
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Floxuridine
1
Dexamethasone
1
Cytoreduction Surgical Procedures
1
Cyclophosphamide
1
Cisplatin
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adrenocortical Carcinoma
×
tipifarnib
×
90 days
×
Clear all
No trials found.